Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Retrospective Study to Describe the Management of Advanced or Metastatic EGFR (Epidermal Growth Factor Receptor) Mutated Non-small Cell Lung Cancer Patients in Spain

NCT01795352 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01795352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01795352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Retrospective Study to Describe the Management of Advanced or Metastatic EGFR (Epidermal Growth Factor Receptor) Mutated Non-small Cell Lung Cancer Patients in Spain
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 31, 2013
Completion date
October 31, 2013
Enrollment
187 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

egfr mutated non-small cell lung cancer patients